Company profile: Molecular Health
1.1 - Company Overview
Company description
- Provider of cloud-based software for evidence-based healthcare decision support and drug development, including MH Guide for genome-based therapy planning for healthcare providers and clinical laboratories, and Dataome, a technology platform that analyzes molecular and clinical patient data against global medical, biological, and pharmacological knowledge to deliver insights for pharmaceutical and biotech professionals.
Products and services
- Dataome Technology: Cloud-based platform that analyzes individual patients’ molecular and clinical data against global medical, biological, and pharmacological knowledge, delivering advanced drug development insights to pharmaceutical and biotech professionals
- MH Guide: Genome-based clinical decision support system that guides therapy planning for healthcare providers and clinical laboratories, focusing treatment selection for individual patients
- Evidence-Based Healthcare Decision Support Software: Big-data-driven products that transform healthcare data into precise, actionable decisions for stakeholders, advancing evidence-based care and smarter drug development strategies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Molecular Health
Azenta
HQ: United States
Website
- Description: Provider of life sciences solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Azenta company profile →
ePharma Solutions
HQ: United States
Website
- Description: Provider of e-clinical solutions that help sponsors, pharmaceutical companies, CROs, and investigator sites accelerate and improve clinical studies through better site selection, training, activation, and management. Offerings include Site Feasibility to find and activate qualified sites globally, and Rater and Patient Training to mitigate bias and variability, improving data quality and standardization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ePharma Solutions company profile →
Atomwise
HQ: United States
Website
- Description: Provider of AI and deep learning–based, structure‑based drug discovery solutions, leveraging supercomputers to identify small‑molecule candidates. Offers AtomNet technology to streamline discovery and develop a pipeline of drug candidates advancing into preclinical studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Atomwise company profile →
Pharma Intelligence
HQ: United Kingdom
Website
- Description: Provider of analysis, insight, and consultancy services for pharmaceutical, MedTech, and clinical research organizations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharma Intelligence company profile →
SnapGene
HQ: United States
Website
- Description: Provider of software to plan, visualize, and document DNA cloning and PCR.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SnapGene company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Molecular Health
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Molecular Health
2.2 - Growth funds investing in similar companies to Molecular Health
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Molecular Health
4.2 - Public trading comparable groups for Molecular Health
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →